Holen Sie sich die Stockscreener-App
3.20
2.14%
-0.07
Handel nachbörslich:
3.21
0.010
+0.31%
Schlusskurs vom Vortag:
$3.27
Offen:
$3.24
24-Stunden-Volumen:
12,204
Relative Volume:
0.03
Marktkapitalisierung:
$7.14M
Einnahmen:
$6,000
Nettoeinkommen (Verlust:
$-3.99M
KGV:
-1.2985
EPS:
-2.4643
Netto-Cashflow:
$-2.85M
1W Leistung:
-5.04%
1M Leistung:
-11.36%
6M Leistung:
-36.00%
1J Leistung:
+67.54%
1-Tages-Spanne:
$3.20
$3.3099
1-Wochen-Bereich:
$3.13
$3.34
52-Wochen-Spanne:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Firmenname
Alaunos Therapeutics Inc
Sektor
Branche
Telefon
(346) 355-4099
Adresse
501 E LAS OLAS BLVD, FORT LAUDERDALE
Vergleichen Sie TCRT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
3.20 | 7.30M | 6,000 | -3.99M | -2.85M | -2.4643 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Aktie (TCRT) Neueste Nachrichten
Retail Surge: Will Alaunos Therapeutics Inc stock maintain dividend yield2025 Dividend Review & AI Forecasted Entry and Exit Points - moha.gov.vn
Will Alaunos Therapeutics Inc stock attract more institutional investorsM&A Rumor & Accurate Entry/Exit Alerts - moha.gov.vn
Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices - Investing.com Canada
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer - TipRanks
Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices By Investing.com - Investing.com South Africa
Why Alaunos Therapeutics Inc. stock could rally in 2025Wall Street Watch & Free Risk Controlled Daily Trade Plans - Улправда
Why Alaunos Therapeutics Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Low Risk High Reward Trade Ideas - Улправда
Risk Check: Can Alaunos Therapeutics Inc. stock outperform in 2025 bull market - Улправда
Will Alaunos Therapeutics Inc. stock maintain dividend yieldEarnings Growth Summary & Consistent Return Investment Signals - DonanımHaber
Will Alaunos Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Momentum & High Return Stock Watch Alerts - DonanımHaber
Will Alaunos Therapeutics Inc. stock split again soon2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Is Alaunos Therapeutics Inc. stock attractive after correctionWeekly Risk Report & Consistent Profit Trade Alerts - Улправда
How strong is Alaunos Therapeutics Inc. stock revenue growthSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru
Stop Loss: Why Alaunos Therapeutics Inc. stock is seen as undervaluedGlobal Markets & Weekly High Return Stock Forecasts - Улправда
Alaunos Therapeutics, Inc. (TCRT) Drops 6% in Pre-market: Trading Without a Clear Catalyst - Stocks Telegraph
Will Alaunos Therapeutics Inc. stock outperform growth indexesEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Will Alaunos Therapeutics Inc. stock recover faster than marketWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Is Alaunos Therapeutics Inc. stock a contrarian buy2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
What momentum indicators show for Alaunos Therapeutics Inc. stock2025 Institutional Moves & Real-Time Volume Analysis - Newser
Alaunos Therapeutics, Inc. (TCRT) 7.38% in After-hours: Momentum Builds Amid Routine Trading - Stocks Telegraph
Alaunos Therapeutics Inc. (TCRT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Alaunos Therapeutics Inc. stock ready for breakout2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
What risks investors should watch in Alaunos Therapeutics Inc. stockWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Is Alaunos Therapeutics Inc. stock cheap compared to fundamentalsRecession Risk & Verified High Yield Trade Plans - newser.com
Can you recover from losses in Alaunos Therapeutics Inc.CEO Change & Technical Confirmation Alerts - newser.com
Can Alaunos Therapeutics Inc. recover in the next quarterPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Risk adjusted return profile for Alaunos Therapeutics Inc. analyzedSell Signal & Safe Entry Momentum Tips - newser.com
Market reaction to Alaunos Therapeutics Inc.’s recent newsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Alaunos Therapeutics, Inc.Common Stock (Nasdaq:TCRT) Stock Quote | User | woonsocketcall.com - Markets Financial Content
News impact scoring models applied to Alaunos Therapeutics Inc.2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Evaluating Alaunos Therapeutics Inc. with trendline analysisQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
How to track smart money flows in Alaunos Therapeutics Inc.Earnings Overview Report & Consistent Return Strategy Ideas - newser.com
Why Alaunos Therapeutics Inc. stock could outperform in 20252025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Ziopharm: Q3 Earnings Snapshot - New Haven Register
Custom strategy builders for tracking Alaunos Therapeutics Inc.July 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
How hedge fund analytics apply to Alaunos Therapeutics Inc. stockWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):